Clarivate buys Piramal's healthcare analytics business for $950 million

With this acquisition, the over $5 billion Clarivate is expected to be well positioned in the $19 billion Life Sciences analytics market, which is enjoying double-digit growth, to support customers across the entire drug, device and medical technology lifecycle from research to outcome.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/360uV5n
via IFTTT